Loading…
Dr. Lal Path Labs (LALPATHLAB)₹2,017+0.38%Healthcare Service Provider
At the end of the Jun 2026 quarter, Dr. Lal Path Labs' shareholders were: promoters 53.15%, FIIs 17.34%, DIIs 21.56%, government 0.01%, public 7.56%, others 0.38%. Promoter holding is down 0.02 percentage points from 53.17% a quarter earlier. FII holding is down 4.34 percentage points from 21.68% a year earlier. 0.00% of promoter shares were pledged. It had 1,11,046 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.57% | 54.56% | 54.56% | 54.56% | 53.88% | 53.87% | 53.87% | 53.75% | 53.17% | 53.17% | 53.17% | 53.15% |
| FIIs | 24.34% | 25.35% | 26.14% | 25.42% | 26.81% | 26.81% | 23.89% | 21.68% | 21.85% | 20.28% | 17.17% | 17.34% |
| DIIs | 8.82% | 9.24% | 9.37% | 12.39% | 12.57% | 12.85% | 15.76% | 17.59% | 18.19% | 19.17% | 21.34% | 21.56% |
| Government | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% | 0.29% | 0.27% | 0.01% | 0.01% | 0.01% |
| Public | 11.57% | 10.19% | 9.32% | 7.04% | 6.12% | 5.90% | 5.92% | 6.30% | 6.15% | 7.02% | 7.97% | 7.56% |
| Others | 0.41% | 0.37% | 0.32% | 0.30% | 0.33% | 0.28% | 0.27% | 0.39% | 0.37% | 0.35% | 0.34% | 0.38% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,60,692 | 1,49,913 | 1,46,753 | 1,31,199 | 1,16,615 | 1,16,245 | 1,15,708 | 1,18,665 | 1,12,712 | 1,16,176 | 1,14,536 | 1,11,046 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Arvind Lal | Promoter | 30.17% | −0.02 |
| Vandana Lal | Promoter | 19.21% | −0.01 |
| Hdfc Mutual Fund - Hdfc Retirement Savings Fund - Equity Plan | DII | 3.95% | New |
| Uti-Mid Cap Fund | DII | 2.65% | New |
| Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund | DII | 2.64% | New |
| Anjaneya Lal | Promoter | 2.01% | 0.00 |
| Smallcap World Fund, Inc | FII | 1.99% | +0.56 |
| Archana Lal Erdmann | Promoter | 1.83% | 0.00 |
| Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Small Cap Fund | DII | 1.79% | +0.37 |
| Life Insurance Corporation Of India | DII | 1.46% | 0.00 |
| Titanium Hybrid Long-Short Fund | DII | 1.42% | New |
| Sbi Nifty Smallcap 250 Etf | DII | 1.38% | New |
| Invesco Oppenheimer International Growth Fund | FII | 1.36% | −0.91 |
| Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund | DII | Exited | — |
| Uti-Flexi Cap Fund | DII | Exited | — |
| Nippon Life India Trustee Ltd-A/C Nippon India Multi Cap Fund | DII | Exited | — |
| Tata Balanced Advantage Fund | DII | Exited | — |
| Sbi Large & Midcap Fund | DII | Exited | — |
| The Brown Capital Management International Small Company Fund | FII | Exited | — |
Promoters held 53.15% of Dr. Lal Path Labs at the end of the Jun 2026 quarter, down 0.60 percentage points from 53.75% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 17.34% (up 0.17 percentage points from 17.17% a quarter earlier) and domestic institutions (DIIs) held 21.56% (up 0.22 percentage points from 21.34% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Dr. Lal Path Labs had 1,11,046 shareholders at the end of the Jun 2026 quarter, against 1,18,665 a year earlier.
Hdfc Mutual Fund - Hdfc Retirement Savings Fund - Equity Plan (DII) held 3.95% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.